New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
10:45 EDTMNKD, MNKDSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Mannkind's inhaled insulin and whether it is approvable on an Analyst/Industry conference call to be held on March 26 at 11 am.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
05:58 EDTMNKDStocks with implied volatility movement; MNKD SHPG
Subscribe for More Information
October 20, 2014
06:52 EDTMNKDMannKind initiated with a Neutral at Goldman
Target $6.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use